Trial of Ebola drug ZMapp launches in Liberia, US

February 27, 2015 11:54 PM

8 0

Trial of Ebola drug ZMapp launches in Liberia, US

The National Institutes of Allergy and Infectious Diseases (NIAID) announced today that it and Liberia's government have launched the first clinical trial of ZMapp, a monoclonal antibody treatment that has been used on an emergency basis to treat some Ebola patients, especially sick health workers who were evacuated from the outbreak region.

In a statement today the NIAID detailed the design of the trial, which will take place at an Ebola treatment center in Monrovia and in the United States at up to four high-containment treatment facilities, including the National Institutes of Health Clinical Center in Bethesda. Md.

Read more

To category page

Loading...